JENNY BIRKS: Open Payments
NPI 1841537859 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,803 in 99 payments from 22 companies in 2025. Trend: 2023 $1,521 · 2024 $3,297 · 2025 $2,803
Food & beverage: $2,656Education: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $667 |
| Sumitomo Pharma America, Inc. | 17 | $418 |
| PFIZER INC. | 9 | $238 |
| Novartis Pharmaceuticals Corporation | 8 | $213 |
| Dendreon Pharmaceuticals LLC | 6 | $176 |
| Astellas Pharma US Inc | 2 | $162 |
| Calyxo, Inc. | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $112 |
| Merck Sharp & Dohme LLC | 5 | $110 |
| IMMUNITYBIO, INC. | 2 | $77 |
Products named: ERLEADA, GEMTESA, XTANDI, PLUVICTO, PROVENGE, CVAC ASPIRATION SYSTEM, LYNPARZA, Nubeqa.
Industry payments across OK — which companies pay providers there.
